Vicarious Surgical Inc. (NYSE:RBOT) Reports Narrower Q2 2025 Loss Amid Cost Optimization Efforts

Vicarious Surgical Inc. (NYSE:RBOT [https://www.chartmill.com/stock/quote/RBOT/profile]) reported its second-quarter 2025 financial results, revealing a net loss per share of $2.23, which was narrower than the analyst consensus estimate of a $2.55 loss. The company reported no revenue for the quarter, in line with expectations, as it continues to focus on developing its surgical robotics platform.

KEY FINANCIAL HIGHLIGHTS

* OPERATING EXPENSES: Declined 24% year-over-year to $13.5 million, reflecting cost optimization efforts.
* R&D EXPENSES: Decreased to $9.1 million from $10.9 million in Q2 2024, as the company progresses toward commercialization.
* CASH POSITION: Ended the quarter with $24 million in cash and investments, with a quarterly cash burn of $13.4 million. Full-year cash burn is projected at approximately $50 million.
* NET LOSS: GAAP net loss improved to $13.2 million ($2.23 per share) from $15.2 million ($2.59 per share) in the prior-year period.

MARKET REACTION

Following the earnings release, Vicarious Surgical's stock saw modest after-hours movement, with a slight uptick of ~0.29%. Over the past month, shares have gained 6.5%, suggesting cautious optimism among investors as the company advances its robotic surgery system.

LEADERSHIP TRANSITION & STRATEGIC FOCUS

The earnings report coincided with a leadership change, with Stephen From assuming the CEO role while co-founder Adam Sachs transitions to President. From emphasized the company’s potential to "reshape the standard of care" with its single-port surgical robot, the Vicarious Surgical System.

LOOKING AHEAD

Analysts currently expect no revenue for fiscal 2025, with a projected full-year EPS loss of $9.63. For Q3 2025, estimates point to a loss of $2.45 per share. The company did not provide specific financial guidance beyond its cash burn outlook.

For more detailed earnings estimates and historical performance, view the full earnings and estimates breakdown [https://www.chartmill.com/stock/quote/RBOT/earnings-estimates].

_Disclaimer: This article is for informational purposes only and does not constitute investment advice._